At a glance
- Originator Pharmacia Corporation
- Class Antipsychotics; Piperazines; Small molecules
- Mechanism of Action Serotonin 2A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psychotic disorders
Most Recent Events
- 29 Dec 2000 Discontinued-Preclinical for Psychotic disorders in Sweden (Unknown route)
- 05 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation